KIMBERLEY PLAYER: Open Payments
NPI 1003062928 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 34 payments from 17 companies in 2025. Trend: 2023 $1,385 · 2024 $2,065 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $216 |
| Abbott Laboratories | 1 | $128 |
| Collegium Pharmaceutical, Inc. | 4 | $72 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $71 |
| Novo Nordisk Inc | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Spinal Simplicity, LLC | 3 | $61 |
| Azurity Pharmaceuticals, Inc. | 3 | $51 |
| Lundbeck LLC | 2 | $35 |
| Averitas Pharma Inc. | 1 | $33 |
Products named: ETERNA, UBRELVY, REXULTI, Belbuca, JOURNAVX, QULIPTA, HA MINUTEMAN G3-R, QUTENZA.
Industry payments across TX — which companies pay providers there.
